Dr. Patnaik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-9268
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Pennsylvania State University College of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2015 - 2026
MA State Medical License 2006 - 2017
MN State Medical License 2004 - 2007- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer Start of enrollment: 2018 Aug 14
Publications & Presentations
PubMed
- 4 citationsPRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (A...Rahul Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus
Journal of Clinical Oncology. 2024-04-01 - 9 citationsSuppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis.Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran
Clinical Cancer Research. 2023-12-01 - 26 citationsRucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRIT...Wassim Abida, David Campbell, Akash Patnaik, Alan H Bryce, Jeremy Shapiro
European Urology. 2023-09-01
Press Mentions
- Free Online Yoga & Meditation Program Supports Healthcare Workers' Mental HealthMarch 23rd, 2021
Author Correction: Pan-Cancer Image-Based Detection of Clinically Actionable Genetic AlterationsNovember 3rd, 2020- PARP Inhibitor Becomes New Treatment Option for Some Men with Advanced Prostate CancerAugust 14th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
